CLA ACIDE LINOLEIQUE CONUGUE
Food supplement declared in France, declaration No 2022-6-582
CLA ACIDE LINOLEIQUE CONUGUE (SANAWEY) is a food supplement declared in France. Status: retrait du marché annoncé pour le 22 November 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- SANAWEY
- Food business operator placing the product on the market
- BioUltime
- Status
- Retrait du marché annoncé pour le 22 November 2026
- Form
- Capsule
- Daily dose
- 3 capsules
- Directions for use
- 3 capsules par jour à avaler avec un verre d'eau, de préférence au cours d'un repas.
- Flavourings
- /
Declaration 184842, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 22 November 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Carthamus tinctorius L. | Graine (huile) | Pression à froid | 3,000 mg |
Additives
E422
Other ingredients
gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- CLA ACIDE LINOLEIQUE CONUGUE SANAWEY, declared in 2022, withdrawn from the market : same declared composition
Brand : SANAWEY